About the Authors
- Shuyan Gu
-
Affiliation Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou City, Zhejiang, China
- Yiming Mu
-
Affiliation Department of Endocrinology and Metabolism, Chinese PLA General Hospital, Chinese PLA Medical College, Beijing, China
- Suodi Zhai
-
Affiliation Department of Pharmacy, Peking University Third Hospital, Beijing, China
- Yuhang Zeng
-
Affiliation Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou City, Zhejiang, China
- Xuemei Zhen
-
Affiliation Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou City, Zhejiang, China
- Hengjin Dong
-
* E-mail: donghj@zju.edu.cn
Affiliation Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou City, Zhejiang, China
Competing Interests
This study was funded by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: SG YM SZ HD. Data curation: SG YZ. Formal analysis: SG YZ XZ. Investigation: SG YZ XZ HD. Methodology: SG YM SZ HD. Project administration: SG HD. Supervision: SG HD. Writing – original draft: SG HD. Writing – review & editing: SG YM SZ HD.